Helping The others Realize The Advantages Of iMDK
All enrolled individuals who acquired at the very least just one dose of zosuquidar or placebo for the duration of induction were being monitored for the occurrence of adverse activities (439 clients, 219 on zosuquidar and 210 on placebo). The commonest adverse situations were linked to the period of prolonged and considerable myelosuppression as i